Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Apr 6.
Published in final edited form as: Addiction. 2018 Dec 5;114(1):101–102. doi: 10.1111/add.14499

Commentary on Madah-Amiri et al. (2019): Beyond saturation

ALEX S BENNETT 1,2, LUTHER ELLIOTT 1,2, BRETT WOLFSON-STOFKO 1,2
PMCID: PMC8985850  NIHMSID: NIHMS1790920  PMID: 30520182

Abstract

Improving upon current uptake rates resulting from naloxone saturation efforts requires that we look beyond existing delivery mechanisms toward novel distribution agents and venues with the greatest potential to reduce overdose (OD) morbidity and mortality.

Keywords: Naloxone, opioids, outreach modalities, overdose prevention, risk environment, saturation


Madah-Amiri et al.’s article is a cogent and timely evaluation of the impacts to be made through national efforts to ‘saturate’ an environment with the overdose reversal medication, naloxone [1]. Given Norway’s careful adherence to empirical estimates about how much naloxone should be provided per capita [2,3] and how to best distribute it [4,5], the study’s findings represent an important indication about what saturation looks like among those whose lives are most likely to depend upon it. In the case of Norway, 57% of participants who reported recent heroin injection were currently in possession of naloxone across six cities with take-home naloxone (THN) programs and one city that did not have a THN program. While that figure should certainly be seen as an indicator of success, it might also be viewed as a powerful provocation to imagine how to achieve a percentage much closer to 100.

Although the ability to access naloxone has greatly increased in Norway and elsewhere, there remain individual, socio-cultural and, for some, structural barriers to seeking and obtaining naloxone [6]. Even in the presence of large-scale distribution programs, a substantial proportion of people at high risk for opioid overdose (OD) do not have the resources, the ability or the wish to possess naloxone. The burden of travel to a service provider, lack of certainty about which service providers offer it and the stigma associated with carrying naloxone are all important barriers that programs should continue to address. For people experiencing homelessness and living unsheltered, a condition often co-occurring with mental health struggles, accessing low-threshold services at all is hardly a given. Further, the study’s authors make clear that ‘possessing’ naloxone can be a slippery concept, as having a reversal kit in one’s home is not the same as having a kit in one’s pocket or bag, ready to be used.

To continue the laudatory work undertaken by Norway and the study’s authors, we advocate for a continued effort to overcome some of the hurdles above and for novel approaches to maximizing naloxone uptake. An important study finding—that drug dealing is a significant predictor of naloxone possession and naloxone use—suggests a potentially efficacious OD intervention. People who sell drugs have been found to be effective syringe distributors and might productively be enlisted as naloxone distributors and OD reversal trainers [7]. Furthermore, the authors’ finding that recent heroin injection is associated with naloxone use reinforces other research indicating that people who use opioids are effective ‘first responders’ [8,9].

Building on the decentralized mobile modality referenced by the authors, communities should explore a greater range of alternative delivery models. Mobile units—typically vans operating under the authority of syringe exchange programs—have been a critical vector for outreach [10]. The expansion of novel distribution methods, such as home delivery of naloxone, can potentially reach a hidden population of people at risk, or people in close connection to others at-risk, who may or may not be involved in networks of drug use or utilize social service agencies that provide naloxone [11].

Locations frequented by people who use drugs should also be provided with naloxone that is visibly available for emergency use. Our recent research suggests that service industry employees encounter drug use, overdoses and syringes in their businesses regularly and are willing to be trained on how to identify and respond to overdoses with naloxone [12]. Standardizing a naloxone distribution system—similar to that seen with automated external defibrillators [13]—would require certain public places (such as restaurants, coffee shops, bars and parks) to be equipped with naloxone. Ideally, implementation of this strategy would begin in local OD hot-spots and quickly expand until public-access naloxone is as commonplace as defibrillators.

In summary, to take naloxone saturation seriously is to recognize that it takes more than an adequate amount of the medication itself within a nation, city or community to effectively ensure that naloxone is present and in the hands of a trained responder, wherever and whenever opioid-related overdoses occur.

Acknowledgements

This research was supported by National Institute on Drug Abuse grant R01DA036754 and R01DA046653. The opinions of the authors do not necessarily reflect those of National Institutes of Health, National Institute on Drug Abuse, or the National Development & Research Institutes.

Footnotes

Declaration of interests

None.

References

  • 1.Madah-Amiri D, Gjersing L, Clausen T Naloxone distribution and possession following a large-scale naloxone programme. Addiction 2018; 10.1111/add.14425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013; 346: f174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bird SM, Parmar MK, Strang J Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland’s public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy 2015; 22: 66–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Clark AK, Wilder CM, Winstanley EL A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med 2014; 8: 153–63. [DOI] [PubMed] [Google Scholar]
  • 5.McDonald R, Strang J Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction 2016; 111: 1177–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Heavey SC, Chang Y-P, Vest BM, Collins RL, Wieczorek W, Homish GG ‘I have it just in case’—naloxone access and changes in opioid use behaviours. Int J Drug Policy 2018; 51: 27–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Friedman SR, de Jong W, Rossi D, Touzé G, Rockwell R, Des Jarlais DC et al. Harm reduction theory: users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. Int J Drug Policy 2007; 18: 107–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bennett AS, Bell A, Doe-Simkins M, Elliott L, Pouget E, Davis C From peers to lay bystanders: findings from a decade of naloxone distribution in Pittsburgh, PA. J Psychoactive Drugs 2018; 50: 240–6. [DOI] [PubMed] [Google Scholar]
  • 9.Wheeler E, Jones TS, Gilbert MK, Davidson PJ, Centers for Disease Control and Prevention Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. Morb Mortal Wkly Rep 2015; 64: 631–5. [PMC free article] [PubMed] [Google Scholar]
  • 10.Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006; 25: 89–96. [DOI] [PubMed] [Google Scholar]
  • 11.McDonald R, Campbell ND, Strang J Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids—conception and maturation. Drug Alcohol Depend 2017; 178: 176–87. [DOI] [PubMed] [Google Scholar]
  • 12.Wolfson-Stofko B, Gwadz MV, Elliott L, Bennett AS, Curtis R ‘Feeling confident and equipped’: evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in new York City. Drug Alcohol Depend 2018; 192: 362–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ringh M, Hollenberg J, Palsgaard-Moeller T, Svensson L, Rosenqvist M, Lippert FK, et al. The challenges and possibilities of public access defibrillation. J Intern Med 2018; 283: 238–56. [DOI] [PubMed] [Google Scholar]

RESOURCES